Skip to main content
Erschienen in: International Journal of Legal Medicine 5/2017

16.05.2017 | Original Article

Medico-legal assessment of methamphetamine and amphetamine serum concentrations—what can we learn from survived intoxications?

verfasst von: Marco Weber, Rüdiger Lessig, Carolin Richter, Axel P. Ritter, Ilona Weiß

Erschienen in: International Journal of Legal Medicine | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Medico-legal experts are increasingly enlisted to assess the methamphetamine and amphetamine serum concentrations after a criminal offense. However, since criminal users rarely provide useful information to medico-legal experts regarding the substances abused, when the substance(s) was/were used, dose of ingestion tools are needed to interpret the analytical data, which can be used as objective evidence in such cases. A comparative series of methamphetamine and amphetamine serum concentrations were used to analyze the frequency of concentrations, to determine methamphetamine/amphetamine concentration ratios, and prove them as a tool to distinguish pure methamphetamine from mixed amphetamine/methamphetamine ingestion. Additionally, two cases of survived accidental methamphetamine intoxication, resulting from ingestion smuggling which was longitudinally monitored, and pharmacokinetic parameters were assessed. In a series of 628 samples where the most frequent concentration of methamphetamine exceeded the therapeutic level, there was a strong correlation suggesting pure methamphetamine consumption, when the ratios of methamphetamine/amphetamine concentrations were within the range between 3 and 10. In the two cases of methamphetamine bodypacking, the relevant serum concentrations of methamphetamine and amphetamine, which could be measured up to 9 days after ingestion, indicated a decrease of the methamphetamine/amphetamine ratios in an exponential manner. However, the ratios were not always within the range between 3 and 10. Lastly, the course of the serum concentrations suggested an increase of the apparent elimination half-life of methamphetamine. In terms of the objective evidence required in criminal law, calculating methamphetamine/amphetamine concentration ratio is not a suitable to means to distinguish pure methamphetamine intake and that of mixed amphetamine/methamphetamine abuse in an individual case. Instead, methamphetamine high serum concentrations and the possible increase in apparent elimination half-life suggest that an extended detection period may be used to distinguish between “illicit use” as compared to “therapeutic use” of methamphetamine.
Literatur
1.
Zurück zum Zitat Courtney KE, Ray LA (2014) Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend 143:11–21CrossRefPubMed Courtney KE, Ray LA (2014) Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend 143:11–21CrossRefPubMed
2.
Zurück zum Zitat Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104(7):1085–1099CrossRefPubMed Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104(7):1085–1099CrossRefPubMed
3.
Zurück zum Zitat Musshoff F, Madea B (2012) Driving under the influence of amphetamine-like drugs. J Forensic Sci 57(2):413–419CrossRefPubMed Musshoff F, Madea B (2012) Driving under the influence of amphetamine-like drugs. J Forensic Sci 57(2):413–419CrossRefPubMed
4.
Zurück zum Zitat Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16(4):R136CrossRefPubMedPubMedCentral Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16(4):R136CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Jones AW, Holmgren A (2012) Concentration ratios of methamphetamine to amphetamine in blood can help to distinguish use of methamphetamine from various mixtures of the two stimulants. J Anal Toxicol 36(9):634–637CrossRefPubMed Jones AW, Holmgren A (2012) Concentration ratios of methamphetamine to amphetamine in blood can help to distinguish use of methamphetamine from various mixtures of the two stimulants. J Anal Toxicol 36(9):634–637CrossRefPubMed
6.
Zurück zum Zitat Li RB, Guan DW, Zhu BL, Zhang GH, Zhao R (2009) Death from accidental poisoning of methamphetamine by leaking into alimentary tract in drug traffic: a case report. Leg Med (Tokyo) 11(Suppl 1):S491–S493CrossRef Li RB, Guan DW, Zhu BL, Zhang GH, Zhao R (2009) Death from accidental poisoning of methamphetamine by leaking into alimentary tract in drug traffic: a case report. Leg Med (Tokyo) 11(Suppl 1):S491–S493CrossRef
7.
Zurück zum Zitat Takekawa K, Ohmori T, Kido A, Oya M (2007) Methamphetamine body packer: acute poisoning death due to massive leaking of methamphetamine. J Forensic Sci 52(5):1219–1222CrossRefPubMed Takekawa K, Ohmori T, Kido A, Oya M (2007) Methamphetamine body packer: acute poisoning death due to massive leaking of methamphetamine. J Forensic Sci 52(5):1219–1222CrossRefPubMed
8.
Zurück zum Zitat Kumral B, Buyuk Y, Yesiloglu F, Ozkan OL (2014) A fatal case of heroin body packing in Turkey. Forensic Toxicol 32(2):338–339CrossRef Kumral B, Buyuk Y, Yesiloglu F, Ozkan OL (2014) A fatal case of heroin body packing in Turkey. Forensic Toxicol 32(2):338–339CrossRef
9.
Zurück zum Zitat Heinemann A, Miyaishi S, Iwersen S, Schmoldt A, Püschel K (1998) Body-packing as cause of unexpected sudden death. Forensic Sci Int 92(1):1–10CrossRefPubMed Heinemann A, Miyaishi S, Iwersen S, Schmoldt A, Püschel K (1998) Body-packing as cause of unexpected sudden death. Forensic Sci Int 92(1):1–10CrossRefPubMed
10.
Zurück zum Zitat Cappelletti S, Piacentino D, Sani G, Bottoni E, Fiore PA, Aromatario M, Ciallella C (2016) Systematic review of the toxicological and radiological features of body packing. Int J Legal Med 130(3):693–709CrossRefPubMed Cappelletti S, Piacentino D, Sani G, Bottoni E, Fiore PA, Aromatario M, Ciallella C (2016) Systematic review of the toxicological and radiological features of body packing. Int J Legal Med 130(3):693–709CrossRefPubMed
11.
Zurück zum Zitat Uekusa K, Hayashida M, Saito N, Mashiko K, Hara K, Waters B, Ohno Y (2013) Methamphetamine and amphetamine concentrations in survivors of body-packer syndrome in Japan. Forensic Sci Int 227(1–3):45–47CrossRefPubMed Uekusa K, Hayashida M, Saito N, Mashiko K, Hara K, Waters B, Ohno Y (2013) Methamphetamine and amphetamine concentrations in survivors of body-packer syndrome in Japan. Forensic Sci Int 227(1–3):45–47CrossRefPubMed
12.
Zurück zum Zitat Shappell SA, Kearns GL, Valentine JL, Neri DF, DeJohn CA (1996) Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol 36(11):1051–1063CrossRefPubMed Shappell SA, Kearns GL, Valentine JL, Neri DF, DeJohn CA (1996) Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J Clin Pharmacol 36(11):1051–1063CrossRefPubMed
13.
Zurück zum Zitat de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet 43(3):157–185CrossRefPubMed de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S (2004) Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices. Clin Pharmacokinet 43(3):157–185CrossRefPubMed
14.
Zurück zum Zitat Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remiao F, Carvalho F, Bastos Mde L (2012) Toxicity of amphetamines: an update. Arch Toxicol 86(8):1167–1231CrossRefPubMed Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remiao F, Carvalho F, Bastos Mde L (2012) Toxicity of amphetamines: an update. Arch Toxicol 86(8):1167–1231CrossRefPubMed
15.
Zurück zum Zitat Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21(4):717–723PubMed Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21(4):717–723PubMed
16.
Zurück zum Zitat Drug and addiction report (2015). The drug commissioner of the federal government, Berlin Drug and addiction report (2015). The drug commissioner of the federal government, Berlin
17.
Zurück zum Zitat Melega WP, Cho AK, Harvey D, Lacan G (2007) Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61(4):216–220CrossRefPubMed Melega WP, Cho AK, Harvey D, Lacan G (2007) Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 61(4):216–220CrossRefPubMed
18.
Zurück zum Zitat Molina NM, Jejurikar SG (1999) Toxicological findings in a fatal ingestion of methamphetamine. J Anal Toxicol 23(1):67–68CrossRefPubMed Molina NM, Jejurikar SG (1999) Toxicological findings in a fatal ingestion of methamphetamine. J Anal Toxicol 23(1):67–68CrossRefPubMed
19.
Zurück zum Zitat Albertson TE, Derlet RW, Van Hoozen BE (1999) Methamphetamine and the expanding complications of amphetamines. West J Med 170(4):214–219PubMedPubMedCentral Albertson TE, Derlet RW, Van Hoozen BE (1999) Methamphetamine and the expanding complications of amphetamines. West J Med 170(4):214–219PubMedPubMedCentral
20.
Zurück zum Zitat de Prost N, Megarbane B, Questel F, Bloch V, Bertaux DC, Pourriat JL, Rabbat A (2010) Blood cocaine and metabolite pharmacokinetics after cardiac arrest in a body-packer case. Hum Exp Toxicol 29(1):49–53CrossRefPubMed de Prost N, Megarbane B, Questel F, Bloch V, Bertaux DC, Pourriat JL, Rabbat A (2010) Blood cocaine and metabolite pharmacokinetics after cardiac arrest in a body-packer case. Hum Exp Toxicol 29(1):49–53CrossRefPubMed
21.
Zurück zum Zitat Anggard E, Jönsson LE, Hogmark AL, Gunne LM (1973) Amphetamine metabolism in amphetamine psychosis. Clin Pharmacol Ther 14(5):870–880CrossRefPubMed Anggard E, Jönsson LE, Hogmark AL, Gunne LM (1973) Amphetamine metabolism in amphetamine psychosis. Clin Pharmacol Ther 14(5):870–880CrossRefPubMed
Metadaten
Titel
Medico-legal assessment of methamphetamine and amphetamine serum concentrations—what can we learn from survived intoxications?
verfasst von
Marco Weber
Rüdiger Lessig
Carolin Richter
Axel P. Ritter
Ilona Weiß
Publikationsdatum
16.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 5/2017
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1607-5

Weitere Artikel der Ausgabe 5/2017

International Journal of Legal Medicine 5/2017 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin